atazanavir sulfate has been researched along with rhodamine 123 in 1 studies
| Studies (atazanavir sulfate) | Trials (atazanavir sulfate) | Recent Studies (post-2010) (atazanavir sulfate) | Studies (rhodamine 123) | Trials (rhodamine 123) | Recent Studies (post-2010) (rhodamine 123) |
|---|---|---|---|---|---|
| 1,102 | 246 | 590 | 1,760 | 10 | 424 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bendayan, R; Chattopadhyay, N; Wong, HL; Wu, XY; Zastre, J | 1 |
1 other study(ies) available for atazanavir sulfate and rhodamine 123
| Article | Year |
|---|---|
Solid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell line.
Topics: Atazanavir Sulfate; Blood-Brain Barrier; Capillary Permeability; Cell Line; Cell Survival; Chemistry, Pharmaceutical; Drug Carriers; Drug Compounding; Endothelial Cells; Fluorescent Dyes; HIV Protease Inhibitors; Humans; Lipids; Microscopy, Fluorescence; Nanoparticles; Oligopeptides; Particle Size; Pyridines; Rhodamine 123; Solubility | 2008 |